Abstract
The quality-adjusted life-year (QALY) is used to measure outcome in rheumatoid arthritis (RA) studies; identification of drivers of a gain in QALY might help predict a treatment response. We investigated how changes in components of the Disease Activity Score-28 joints (DAS28) were associated with the European League Against Rheumatism (EULAR) and European Quality of Life 5 Dimensions (EQ-5D) responses; and what baseline variables predicted the change in QALY following 1 year of biological therapy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Rheumatology |
Vol/bind | 40 |
Udgave nummer | 9 |
Sider (fra-til) | 1479-86 |
Antal sider | 8 |
ISSN | 0315-162X |
DOI | |
Status | Udgivet - sep. 2013 |